Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | -0.01% | 78.32 | 0.7% | $1640.63m | |
| JNJ | Johnson & Johnson | 0.72% | 161.26 | 0.7% | $1027.09m | |
| PFE | Pfizer Inc. | -0.38% | 41.51 | 0.9% | $984.93m | |
| ABBV | AbbVie, Inc. | 0.41% | 109.36 | 1.9% | $719.23m | |
| BMY | Bristol-Myers Squibb Co. | 1.11% | 58.34 | 1.0% | $691.66m | |
| LLY | Eli Lilly & Co. | 0.55% | 237.98 | 1.1% | $629.67m | |
| AZN | AstraZeneca Plc | 0.92% | 60.22 | 1.0% | $377.08m | |
| NVS | Novartis AG | 0.90% | 83.34 | 0.2% | $177.37m | |
| GSK | GlaxoSmithKline Plc | 0.75% | 39.01 | 0.2% | $158.74m | |
| RGEN | Repligen Corp. | -0.61% | 266.92 | 6.8% | $129.47m | |
| AVIR | Atea Pharmaceuticals, Inc. | -2.89% | 39.28 | 0.3% | $121.41m | |
| CRVS | Corvus Pharmaceuticals, Inc. | -3.51% | 4.95 | 0.7% | $109.87m | |
| VTRS | Viatris, Inc. | -0.15% | 13.46 | 0.0% | $98.18m | |
| NVO | Novo Nordisk A/S | 1.89% | 102.34 | 0.1% | $90.55m | |
| RPRX | Royalty Pharma Plc | 3.59% | 38.39 | 0.1% | $87.06m |
Company Profile
GH Research Plc operates as a holding company which through its subsidiaries provides biopharmaceutical products and services. It develops therapeutic products for the patients who are suffering from Treatment Resistant Depression (TRD). The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.